If Trump recovers quickly it will be because he had elite access to Regeneron's experimental drug
not because he so "healthy" or has good genes, as he might try to claim later. Without this drug, he would be FAR worse off. There's a real question whether even his associates who got sick in his cohort (think Chris Christie) will have the same access, forget normal people.
This article came just a day before Trump's sickness was revealed:
https://www.sciencemag.org/news/2020/09/provocative-results-boost-hopes-antibody-treatment-covid-19
‘Provocative results’ boost hopes of antibody treatment for COVID-19
By Jon Cohen Sep. 30, 2020 , 5:15 PM
-snip-
"A second company has now produced strong hints that monoclonal antibodies, synthetically produced versions of proteins made by the immune system, can work as treatments in people who are infected with the pandemic coronavirus but are not yet seriously ill.
The biotech Regeneron Pharmaceuticals has developed a cocktail of two monoclonal antibodies that attach to the surface protein of that coronavirus, SARS-CoV-2, and attempt to block it from infecting cells. Yesterday at an investor and media webcast, the firm revealed early results.
Infected people in a placebo-controlled trial that ultimately plans to enroll 2100 individuals who are asymptomatic or, at worst, moderately ill. The analysis divides patients into two groups: those who had detectable antibodies against SARS-CoV-2 at the trial’s start and those who did not, a so-called seronegative group. The monoclonal cocktail showed little effect on people who already had antibodies against the virus. But it appeared to help the seronegative patients, powerfully reducing the amount of virus found in nasopharyngeal swabs and alleviating symptoms more quickly. “These are provocative results,” says Myron Cohen of the University of North Carolina, Chapel Hill, who was not involved with the study but is helping Regeneron test its monoclonal cocktail as a preventive.
--snip--
Both Lilly and Regeneron say they are discussing their data with regulators to see whether their monoclonal antibodies might warrant moving to widespread use more quickly through mechanisms like the U.S. Food and Drug Administration’s emergency use authorization process. Additional studies of their monoclonal treatments are underway in hospitalized COVID-19 patients and, separately, as preventives in uninfected people.
Monoclonal antibodies are more difficult to make than many drugs and often are extremely expensive, which means that supply could outstrip demand and many countries might not be able to afford them. The U.S. government’s Operation Warp Speed has invested $450 million in Regeneron to produce up to 300,000 “doses” of its cocktail by the end of the year, which would be distributed to Americans free of charge. “A substantial fraction of those are already available,” Yancopoulos said—although it’s not yet clear what constitutes a single dose of the company’s cocktail. Nonetheless, Regeneron, which is partnering with Roche to increase production capability, says it hopes to ramp up to produce 250,000 doses per month."
--MORE AT LINK--
-----------
Trump may well recover quickly-- don't put it down to his great health, but to his special access to an experimental therapy that will eventually be game changers for Covid-19. In the article, it is mentioned that Eli Lilly has a similar drug and that 1,000,000 doses could be available by the end of the year.
= new reply since forum marked as read
